SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-049984
Filing Date
2024-04-22
Accepted
2024-04-22 16:08:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm242755d2_defa14a.htm DEFA14A 15144
2 GRAPHIC tm242755d2_defa14aimg001.jpg GRAPHIC 447751
3 GRAPHIC tm242755d2_defa14aimg002.jpg GRAPHIC 188273
  Complete submission text file 0001104659-24-049984.txt   892502
Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36279 | Film No.: 24861264
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)